any news on the launches? why is this thing going up?
The desire of Switzerland's Renovo to find a licensing partner for it's wound healing treatment Juvista was well known.The market was caught off balance when Shire ,who have no dermatology franchise and are new to this field have landed the spoils.The total payments (including all milestone payments)comes to $825mThis is already a good drug and, if it can break into the lucrative plastic surgery market,could be huge.
sounds good, I was surprised to see the dermatology spin. any word on vyvanse's progress?